openPR Logo
Press release

Maximizing ROI of Pharma Competitive Intelligence

07-15-2020 10:16 AM CET | Health & Medicine

Press release from: BiopharmaVantage

/ PR Agency: BiopharmaVantage

Maximizing ROI of pharmaceutical competitive intelligence engagements is vital for a variety of reasons. BiopharmaVantage, the specialist pharma competitive intelligence firm describes the key success factors that users need to focus on in order to maximize the ROI of engagements. The firm recommends the usage of the following multi-factor framework:

Aren’t they well known?
Collectors become defenders
Consulting firm aspirants
Procuring non-core services of suppliers
Learn from the evolving market
An agency with ex-pharma employees
Intelligence collection is the bulk of the work
Asset-focused executives
Rigid buying process

About BiopharmaVantage

BiopharmaVantage is a specialist firm that specializes in providing premium quality competitive intelligence services to pharmaceutical and biotechnology companies. If you would like to discuss how we can assist you, then please contact us.

 

Contact:

Katherine Mae

Business Development Manager

BiopharmaVantage, Oxford, UK

Email: enquiries@biopharmavantage.com

Website: www.biopharmavantage.com

 

BiopharmaVantage, Oxford, UK

BiopharmaVantage is a specialist firm that specializes in providing premium quality competitive intelligence services to pharmaceutical and biotechnology companies. If you would like to discuss how we can assist you, then please contact us.

 

Contact:

Katherine Mae

Business Development Manager

BiopharmaVantage, Oxford, UK

Email: enquiries@biopharmavantage.com

Website: www.biopharmavantage.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Maximizing ROI of Pharma Competitive Intelligence here

News-ID: 2090004 • Views:

More Releases from BiopharmaVantage

Pharma valuation expert, BiopharmaVantage advises on the valuation of a pharmaceutical company developing COVID therapeutics
Pharma valuation expert, BiopharmaVantage advises on the valuation of a pharmace …
Pharma and Biotech valuation expert, BiopharmaVantage is delighted to announce that it has advised on the valuation of an early-stage pharmaceutical company (the client) seeking investment. The early-stage company utilizes a de-risked platform for devising therapeutics for various indications, and the lead asset is an intervention for the treatment of COVID 19 patients. The engagement lead at BiopharmaVantage commented- ‘COVID has significantly affected the products portfolio of pharmaceutical companies. The industry
Demystifying pharma COGS competitive intelligence
Demystifying pharma COGS competitive intelligence
COGS, aka the cost of goods sold, is one of the key intelligence questions that frequently emerges in the pharma competitive intelligence engagements. BiopharmaVantage, the specialist pharma competitive intelligence firm, describes the issues with COGS so that end-users leverage such intelligence judiciously in their pharma intelligence collection exercises. These include: • Understanding of the meaning of COGS • Impact of method of accounts • Impact of accounting policies • Global footprint of pharma value chain • Learn from the evolving

More Releases for Oxford

Cryogen Free Dilution Refrigerators Market to 2025 | Oxford Instruments, Cryomag …
Market Research Hub (MRH) has actively included a new research study titled Global Cryogen Free Dilution Refrigerators Market Insights, Forecast to 2025 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until forecast period
Cryogen Free Dilution Refrigerators Market to 2025 | Oxford Instruments, Cryomag …
Market Research Hub (MRH) has actively included a new research study titled Global Cryogen Free Dilution Refrigerators Market Insights, Forecast to 2025 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until forecast period
NHS Dentist Oxford – Damira Dental
Damira Dental Bury Knowle is an excellent NHS Dentist in Oxford dedicated to providing exceptional levels of NHS dental care. Established in 2003, Damira Dental Studios has grown from this one small practice in Oxford to a leading provider of high quality dentistry across Southern England. Damira Dental now comprises 18 practices across London, Hampshire and Oxfordshire! They offer a comprehensive range of treatments both through the NHS and privately
Oxford Instruments awarded Best Technology Company 2012
Oxford Instruments plc, a leading provider of high technology tools and systems for research and industry, has won the award for Best Technology Company 2012 at the annual PLC Awards. The awards, sponsored by Price Waterhouse Coopers, reward excellence amongst the smaller companies quoted on the London Stock Exchange. Attracting more than 1,500 guests, including quoted companies, investment banks, fund managers, investment analysts and corporate advisors, the awards are 'the' City
Oxford Gene Technology and Abcodia form Partnership
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced a collaborative agreement with Abcodia, a specialist company engaged in the validation and discovery of biomarkers of cancer and other age-related diseases, aimed at improving the early detection of pancreatic cancer. As part of this collaboration, Abcodia will provide access to its large prospective serum biobank, to harness samples taken from
Oxford Instruments plc enters the FTSE 250
The FTSE Group has announced that Oxford Instruments plc, the leading provider of high technology tools and systems for industry and research, has been promoted to the FTSE 250 index. Jonathan Flint, Chief Executive, says “Joining the FTSE 250 is an outstanding milestone for Oxford Instruments and something all our employees can be extremely proud of. It reflects the huge steps forward the Group has made during recent times, successfully